Non-Ischemic Myocardial Fibrosis in End-Stage Kidney Disease Patients: A New Perspective
Cardiovascular medicine, especially for ischemic heart disease, has evolved and advanced over the past two decades, leading to substantially improved outcomes for patients, even those with chronic kidney disease. However, the prognosis for patients with end-stage kidney disease (ESKD) has not improv...
Saved in:
Main Authors: | Kenji Nakata (Author), Nobuhiko Joki (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular Calcification in Diabetic Kidney Disease
by: Olivier Phan, et al.
Published: (2022) -
Tenapanor: A new treatment option for hyperphosphatemia in end stage kidney disease
by: Tiffany Lin, et al.
Published: (2022) -
The importance of psychiatric disorders in end-stage kidney disease patients
by: Eun Lee
Published: (2022) -
End-stage kidney disease in LMICs: rising to the challenge
by: The Lancet Global Health
Published: (2017) -
Preoperative Evaluation in Patients With End-Stage Renal Disease and Chronic Kidney Disease
by: Rabih Nasr, et al.
Published: (2017)